Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus aureus and...

Area of Science:

• Medicinal Chemistry
• Microbiology
• Pharmacology

Background:

• Lipophilic vancomycin analogues enhance bacterial cell wall interactions but often suffer from long half-lives and toxicity.
• Hydrophilic fragments are crucial for modulating the pharmacokinetic/pharmacodynamic properties of lipo-vancomycin.

Purpose of the Study:

• To synthesize and evaluate novel vancomycin analogues with enhanced efficacy and improved pharmacokinetic profiles.
• To investigate the structure-activity relationships of vancomycin derivatives with sugar moieties and lipophilic substitutions.

Main Methods:

• Synthesis of vancomycin analogues with varied sugar moieties and lipophilic substitutions.
• Structure-activity relationship analysis against methicillin-susceptible S. aureus, vancomycin-intermediate resistant S. aureus (VISA), and vancomycin-resistant Enterococci (VRE).
• In vivo pharmacokinetic studies to assess half-life and toxicity.

Main Results:

• Optimal analogues exhibited 128-1024-fold higher activity compared to vancomycin against tested resistant bacteria.
• Introduction of extra sugar motifs effectively regulated pharmacokinetic properties, shortening the elimination half-life.
• The modified vancomycin derivatives demonstrated reduced accumulative toxicity.

Conclusions:

• Introducing extra sugars to lipo-vancomycin is an effective strategy for developing superior antibiotic analogues.
• These novel derivatives possess enhanced efficacy, optimized pharmacokinetics, and reduced toxicity, addressing key limitations of existing lipo-vancomycins.
• This approach offers a promising pathway for designing next-generation vancomycin-based antibiotics against drug-resistant pathogens.